Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane

NCT01773460 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Study was stopped terminated early due to low recruitment.

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Everolimus
DRUG: Everolimus-placebo

Sponsor

GBG Forschungs GmbH

Collaborators

[object Object]